Zobrazeno 1 - 10
of 3 570
pro vyhledávání: '"Neisseria meningitidis serogroup"'
Autor:
García A; GSK, Tres Cantos, Spain. Electronic address: andrea.x.garcia@gsk.com., Vallejo-Aparicio LA; GSK, Tres Cantos, Spain., Begum N; Freelance C/O GSK, Wavre, Belgium., Nikitas G; GSK, Wavre. Belgium., González-Inchausti C; GSK, Tres Cantos, Spain., de Gomensoro E; GSK, Tres Cantos, Spain.
Publikováno v:
Vaccine [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126155. Date of Electronic Publication: 2024 Aug 14.
Autor:
Manoharan S; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom., Farman TA; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom., Piliou S; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom., Mastroeni P; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Sep 24; Vol. 15, pp. 1473064. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).
Autor:
Efron A; Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina., Brozzi A; GSK, Siena, Italy., Biolchi A; GSK, Siena, Italy., Bodini M; GSK, Siena, Italy., Giuliani M; GSK, Siena, Italy., Guidotti S; GSK, Siena, Italy., Lorenzo F; Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina., Moscoloni MA; Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina., Muzzi A; GSK, Siena, Italy., Nocita F; GSK, Buenos Aires, Argentina., Pizza M; GSK, Siena, Italy., Rappuoli R; GSK, Siena, Italy., Tomei S; GSK, Siena, Italy., Vidal G; GSK, Buenos Aires, Argentina., Vizzotti C; National Ministry of Health (2010-2015 and 2019-2023), Buenos Aires, Argentina., Campos J; Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina., Sorhouet Pereira C; Instituto Nacional de Enfermedades Infecciosas-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2378537. Date of Electronic Publication: 2024 Jul 22.
Autor:
Muzzi A; GSK, Siena, Italy., Lu M-C; School of Medicine, China Medical University, Taichung, Taiwan., Mori E; GSK, Siena, Italy., Biolchi A; GSK, Siena, Italy., Fu T; GSK, Taipei, Taiwan., Serino L; GSK, Siena, Italy.
Publikováno v:
MSphere [mSphere] 2024 Jun 25; Vol. 9 (6), pp. e0022024. Date of Electronic Publication: 2024 May 16.
Autor:
Palmieri C; Interdisciplinary Department of Medicine, Hygiene Unit, University of Bari Aldo Moro, Bari, Italy., Moscara L; Interdisciplinary Department of Medicine, Hygiene Unit, University of Bari Aldo Moro, Bari, Italy., Tafuri S; Interdisciplinary Department of Medicine, Hygiene Unit, University of Bari Aldo Moro, Bari, Italy., Stefanizzi P; Interdisciplinary Department of Medicine, Hygiene Unit, University of Bari Aldo Moro, Bari, Italy.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2396220. Date of Electronic Publication: 2024 Sep 12.
Autor:
Herrera-Restrepo O; GSK, Philadelphia, PA, USA., Clements DE; GSK, Philadelphia, PA, USA., Hebert ZN; Verilogue, Philadelphia, PA, USA., McCracken C; Verilogue, Philadelphia, PA, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2024 Jul; Vol. 40 (7), pp. 1253-1263. Date of Electronic Publication: 2024 Jun 14.
Publikováno v:
Emerging infectious diseases [Emerg Infect Dis] 2024 May; Vol. 30 (5), pp. 1009-1012.
Autor:
Cheng Y; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Shen R; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Liu F; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Li Y; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Wang J; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Hou Y; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Liu Y; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Zhou H; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Hou F; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Wang Y; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Li X; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China., Qiao R; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China. Electronic address: Qruijie@126.com., Luo S; Lanzhou Institute of Biological Products Co., Ltd., Lanzhou 730046, China. Electronic address: sqluo@vacmic.com.
Publikováno v:
Vaccine [Vaccine] 2024 Apr 19; Vol. 42 (11), pp. 2781-2792. Date of Electronic Publication: 2024 Mar 19.
Autor:
Collins JP, Crowe SJ, Ortega-Sanchez IR, Bahta L, Campos-Outcalt D, Loehr J, Morgan RL, Poehling KA, McNamara LA
Publikováno v:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Apr 18; Vol. 73 (15), pp. 345-350. Date of Electronic Publication: 2024 Apr 18.
Autor:
Kekeisen-Chen JF, Tarbangdo FT, Sharma S, Marasini D, Marjuki H, Kibler JL, Reese HE, Ouattara S, Ake FH, Yameogo I, Ouedraogo I, Seini E, Zoma RL, Tonde I, Sanou M, Novak RT, McNamara LA
Publikováno v:
Emerging infectious diseases [Emerg Infect Dis] 2024 Mar; Vol. 30 (3), pp. 460-468.